Concepedia

Inder Bhamra

IB

6

Publications

132

Citations

6

H-Index

2006

Active since

Affiliations

University of Liverpool(Current)

Redx Pharma (United Kingdom)

Inder Bhamra is an author at University of Liverpool specializing in drug discovery, organic chemistry, and pharmacotherapy.

Top concepts

Publications per year

2006–2022

6

Publications

6

N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: Indazoles as phenol isosteres with improved pharmacokinetics

Paul Bamborough, Richard Angell, Inder Bhamra et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 49 citations · Full text

, , +7

The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand–dependent Cancer Models

Caroline Phillips, Inder Bhamra, Catherine Eagle et al. · Cancer Research Communications · 2022 · 27 citations · Full text

Base-pairing preferences, physicochemical properties and mutational behaviour of the DNA lesion 8-nitroguanine †

Inder Bhamra, Patricia Compagnone-Post, Ian A. O’Neil et al. · Nucleic Acids Research · 2012 · 24 citations · Full text

Abstract 506: Wnt/â-Catenin pathway inhibitor RXC004 enhances the immunity of pre-clinical models of cancer

Caroline Phillips, Inder Bhamra, Catherine Eagle et al. · Cancer Research · 2019 · 11 citations · Full text

α-Lithio quinuclidine N-oxide (Li-QNO): A new base for synthetic chemistry

Ian A. O’Neil, Inder Bhamra, Peter Gibbons · Chemical Communications · 2006 · 11 citations

, , +10

Rows per page

1–5 of 6